Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INSULET CORPORATION

(PODD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/21/2021 07/22/2021 07/23/2021 07/26/2021 07/27/2021 Date
271.48(c) 271.46(c) 276.55(c) 263.67(c) 266.85(c) Last
238 128 208 089 261 217 295 180 272 318 Volume
-0.52% -0.01% +1.88% -4.66% +1.21% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 1 083 M - -
Net income 2021 46,8 M - -
Net Debt 2021 228 M - -
P/E ratio 2021 371x
Yield 2021 -
Sales 2022 1 305 M - -
Net income 2022 101 M - -
Net Debt 2022 142 M - -
P/E ratio 2022 175x
Yield 2022 -
Capitalization 17 684 M 17 684 M -
EV / Sales 2021 16,5x
EV / Sales 2022 13,7x
Nbr of Employees 1 900
Free-Float 99,6%
More Financials
Company
Insulet Corporation is primarily engaged in the development, manufacture and sale of its proprietary Omnipod System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod Insulin Management System (Omnipod), the Omnipod DASHTM Insulin Management System (Omnipod DASH) and its digital mobile Omnipod platform. The Omnipod System features two devices: a... 
More about the company
Ratings of Insulet Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about INSULET CORPORATION
07/26INSULET : to Present at Upcoming Investor Conferences
BU
07/21INSULET : Cowen Analyst Assumes Coverage on Outperform-Rated Insulet, Sets $310 ..
MT
07/20INSULET : SVB Leerink Adjusts Price Target for Insulet to $325 From $300, Mainta..
MT
07/02INSIDER TRENDS : Insulet Insider Disposition Eases Back 90-Days of Buys
MT
07/01INSULET : to Announce Second Quarter 2021 Financial Results on August 5, 2021
BU
06/28INSULET : Wearable Insulin Delivery System Shows Improved Outcomes in Children i..
MT
06/26INSULET : Omnipod« 5 Automated Insulin Delivery System Pivotal Studies Demonstra..
BU
06/26Insulet Corporation’S Omnipod« 5 Automated Insulin Delivery System Pivotal St..
CI
06/24INSULET : to Present New Clinical Data for Preschool Children and Adults using t..
BU
06/24Insulet Corporation to Present New Clinical Data for Preschool Children and A..
CI
06/22Insulin pump Accessories Market Development, Outline, Competitive perspective..
AQ
06/15INSULET CORP : Unregistered Sale of Equity Securities (form 8-K)
AQ
06/08INSULET : Significant Insider Selling in Shares of Insulet (PODD) Continues
MT
06/07INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at Insulet
MT
06/03INSIDER TRENDS : Insulet Sees 90 Days of Insider Buying Trend Slowing with Share..
MT
More news
News in other languages on INSULET CORPORATION
07/01Ypsomed pourra étoffer son capital-actions comme son conseil d'administration
07/01Ypsomed-Aktionäre genehmigen an GV Kapitalerhöhung
05/26Ventes en progression mais bénéfice annuel divisé par deux pour Ypsomed
05/26Ventes en progression mais bénéfice divisé par deux pour Ypsomed
05/26Ypsomed steigert Umsatz, schreibt aber weniger Gewinn
More news
Analyst Recommendations on INSULET CORPORATION
More recommendations
Chart INSULET CORPORATION
Duration : Period :
Insulet Corporation Technical Analysis Chart | PODD | US45784P1012 | MarketScreener
Technical analysis trends INSULET CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 266,85 $
Average target price 282,79 $
Spread / Average Target 5,97%
EPS Revisions
Managers and Directors
Shacey Petrovic President, Chief Executive Officer & Director
Wayde Dwight McMillan Chief Financial Officer, Treasurer & Executive VP
Timothy J. Scannell Independent Chairman
Trang Ly Senior Vice President & Medical Director
Charles Alpuche Chief Operations Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
INSULET CORPORATION3.15%17 684
ABBOTT LABORATORIES9.43%212 366
MEDTRONIC PLC11.17%172 114
BECTON, DICKINSON AND COMPANY1.79%72 539
HOYA CORPORATION5.22%50 566
ALIGN TECHNOLOGY, INC.17.05%50 298